Knowledge Graph
Graph explorer
Search resolved entities, walk their edges, and read the sentence behind every one.
Entities25 of 207,987
- large language modeltechnology1,048 mentions
- robotic manipulationmarket834 mentions
- artificial intelligencetechnology739 mentions
- reinforcement learningtechnology492 mentions
- density-functional theorytechnology386 mentions
- Transformertechnology372 mentions
- vision-language-action modeltechnology355 mentions
- agentic AItechnology353 mentions
- Vision-Language Modeltechnology321 mentions
- U.S. Food and Drug Administrationorganization320 mentions
- Microsoftorganization291 mentions
- Googleorganization277 mentions
- NVIDIAorganization265 mentions
- Model Context Protocoltechnology232 mentions
- machine learningtechnology204 mentions
- MarketsandMarketsorganization199 mentions
- Claudeproduct192 mentions
- AI agenttechnology188 mentions
- ChatGPTproduct178 mentions
- Anthropicorganization177 mentions
- integrated sensing and communicationtechnology176 mentions
- Amazon Web Services, Inc.organization174 mentions
- OpenAIorganization172 mentions
- diffusion modeltechnology170 mentions
- IBMorganization163 mentions
Entity
QTORIN rapamycin
product1 mentionslast seen Oct 28, 2026
3.9% rapamycin anhydrous gel for treatment of microcystic lymphatic malformations.
Relationships 8
- QTORIN rapamycinapplies tomicrocystic lymphatic malformation treatment95% confidence1 source
- Palvella Therapeutics, Inc.developsQTORIN rapamycin90% confidence1 source
- QTORIN rapamycinconforms toFDA Orphan Drug designation90% confidence1 source
- QTORIN rapamycinconforms toFDA Breakthrough Therapy designation90% confidence1 source
- U.S. Food and Drug AdministrationapprovesQTORIN rapamycin90% confidence1 source
- QTORIN rapamycinapplies tocutaneous venous malformation treatment85% confidence1 source
- QTORIN rapamycinapplies toclinically significant angiokeratoma treatment85% confidence1 source
- QTORIN rapamycindepends onQTORIN platform80% confidence1 source
Sources
Select a relationship to read the sources behind it.